Who are Bausch + Lomb Corporation's main suppliers?

Bausch + Lomb Corporation (BLCO) key suppliers include: WHITECAP-BIOSCIENCES, Bausch Health Companies Inc., LENSAR, Inc.. View the full supplier network at chainsifter.com/chain/BLCO.

Who are Bausch + Lomb Corporation's major customers?

Bausch + Lomb Corporation (BLCO) key customers include: PAYORS, NOVALIQ-GMBH, Johnson & Johnson, Johnson & Johnson, BAUSCH-HEALTH-AMERICAS-INC and 6 more. View the full customer network at chainsifter.com/chain/BLCO.

What sector is Bausch + Lomb Corporation in?

Bausch + Lomb Corporation (BLCO) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Bausch + Lomb Corporation Supplier List (BLCO): 3 Verified Suppliers

3Suppliers

11Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Bausch + Lomb Corporation (BLCO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

16Total relationships

1Distinct source URLs

5High confidence

0.726Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Bausch + Lomb Corporation Suppliers

Ticker	Name	Confidence	Evidence
WHITECAP-BIOSCIENCES	WHITECAP-BIOSCIENCES	85%	On January 3, 2025, the Company, through its affiliate, acquired Whitecap Biosciences, LLC, (Whitecap Biosciences) for an upfront payment of approximately $ 28 million
BHC	Bausch Health Companies Inc.	72%	Reciprocal relationship from BHC graph: Reciprocal relationship from BLCO graph: Reciprocal relationship from BHC graph: Reciprocal relationship from BLCO graph: Reciprocal relationship from BHC grap…
LNSR	LENSAR, Inc.	72%	Reciprocal relationship from LNSR graph: antee that the Company will be able to meet customer demand for the ALLY System. In addition, pricing increases in component parts for our Systems resulting f…

Bausch + Lomb Corporation Customers

Ticker	Name	Confidence	Evidence
PAYORS	PAYORS	90%	We also concentrate on managing our relationships with our payors and wholesalers
NOVALIQ-GMBH	NOVALIQ-GMBH	85%	utable to the increase in our operating results, as previously discussed. Investing Activities Net cash used in investing activities was $130 million and $116 million for the three months ended March…
JNJ	Johnson & Johnson	72%	itrust Generic Pricing Antitrust Litigation BHC and its subsidiaries, Oceanside Pharmaceuticals, Inc., Bausch Health US, LLC (formerly Valeant Pharmaceuticals North America LLC) (“Bausch Health US”),…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from BLCO graph: itrust Generic Pricing Antitrust Litigation BHC and its subsidiaries, Oceanside Pharmaceuticals, Inc., Bausch Health U…
BAUSCH-HEALTH-AMERICAS-INC	BAUSCH-HEALTH-AMERICAS-INC	62%	itrust Generic Pricing Antitrust Litigation BHC and its subsidiaries, Oceanside Pharmaceuticals, Inc., Bausch Health US, LLC (formerly Valeant Pharmaceuticals North America LLC) (“Bausch Health US”),…
BDCO	Blue Dolphin Energy Company	62%	Reciprocal relationship from BDCO graph: Reciprocal relationship from BLCO graph: utable to the increase in our operating results, as previously discussed. Investing Activities Net cash used in inves…
BHC	Bausch Health Companies Inc.	62%	Reciprocal relationship from BHC graph: Reciprocal relationship from BLCO graph: Reciprocal relationship from BHC graph: Reciprocal relationship from BLCO graph: Reciprocal relationship from BHC grap…
LOMB-INCORPORATED	LOMB-INCORPORATED	62%	utable to the increase in our operating results, as previously discussed. Investing Activities Net cash used in investing activities was $130 million and $116 million for the three months ended March…
OCEANSIDE-PHARMACEUTICALS-INC-BAUSCH-HEALTH-US-L	OCEANSIDE-PHARMACEUTICALS-INC-BAUSCH-HEALTH-US-L	62%	itrust Generic Pricing Antitrust Litigation BHC and its subsidiaries, Oceanside Pharmaceuticals, Inc., Bausch Health US, LLC (formerly Valeant Pharmaceuticals North America LLC) (“Bausch Health US”),…
VALEANT-PHARMACEUTICALS-NORTH-AMERICA-LLC	VALEANT-PHARMACEUTICALS-NORTH-AMERICA-LLC	62%	itrust Generic Pricing Antitrust Litigation BHC and its subsidiaries, Oceanside Pharmaceuticals, Inc., Bausch Health US, LLC (formerly Valeant Pharmaceuticals North America LLC) (“Bausch Health US”),…
WHITECAP-BIOSCIENCES-LLC	WHITECAP-BIOSCIENCES-LLC	62%	ociated with this acquisition during the period from December 9, 2025 through December 31, 2025 were not material. Pro forma revenues and operating results for the years 2025 and 2024 were not materi…

Bausch + Lomb Corporation Debt Obligations

Instrument	Description	Confidence	Evidence
BLCO-DEBT	Debt stack $5.1B	90%	Market cache reports total debt of $5.1B.

Bausch + Lomb Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Bausch + Lomb Corporation.

Bausch + Lomb Corporation Ownership

Holder	Name	Confidence	Evidence
BLCO-OWNER-OAKTREE-CAPITAL-MANAGEMENT-LP	OAKTREE CAPITAL MANAGEMENT LP	90%	13F overlay lists OAKTREE CAPITAL MANAGEMENT LP as top holder; 96 tracked holders.

Bausch + Lomb Corporation Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ADGM	Adagio Medical Holdings, Inc.	100.00	2
ATON	AlphaTON Capital Corp	100.00	2
CLGN	CollPlant Biotechnologies Ltd.	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
ACIU	AC Immune SA	100.00	2
AURA	Aura Biosciences, Inc.	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
ATRA	Atara Biotherapeutics, Inc.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
ABBV	AbbVie Inc.	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
AORT	Artivion, Inc.	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
ALC	Alcon Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
BDCO	Blue Dolphin Energy Company	100.00	1	['customer']
FDMT	4D Molecular Therapeutics, Inc.	100.00	2

Bausch + Lomb Corporation Supply Chain